Additionally, a study on renal cancer revealed that HGF/c-Met enhances the level of nuclear factor E2-related factor 2 (Nrf2), thereby alleviating oxidative stress and apoptosis, both in vitro and in vivo [55]. This evidence concerns the gene MET and renal carcinoma.